MedPageToday
MedPage Today) — Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer’s disease diagnoses in people with type 2 diabetes, observational data showed.
In emulation target trials involving more than 1 million eligible diabetes patients…
Read More
Ozempic Linked With Lower Risk of Alzheimer’s Diagnosis
Rebecka Fleishman
16:19
MedPage Today) — Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer’s disease diagnoses in people with type 2 diabetes, observational data showed. In emulation target trials involving more than 1 million eligible diabetes patients…
